Table 2.
Stage | Median survival in (months) |
95 % CI | X 2 | p value | Hazard ratio | CI | p value |
---|---|---|---|---|---|---|---|
Combined | 48.00 | 47.00–50.00 | 13.94 | <0.001 | 1.67 | 1.26–2.22 | 0.001 |
IB | |||||||
CCRT Arm | 57.00 | 54.00–60.00 | 0.655 | 0.418 | 0.404 | 0.04–3.90 | 0.434 |
NACT Arm | 50.00 | 48.00–58.00 | – | – | – | ||
IIA | |||||||
CCRT Arm | 57.00 | 54.00–60.00 | 0.141 | 0.707 | 0.712 | 0.119–4.26 | 0.710 |
NACT Arm | 54.00 | 50.00–57.00 | – | – | – | ||
IIB | |||||||
CCRT Arm | 52.00 | 50.00–54.00 | 0.765 | 0.382 | 1.529 | 0.582–4.01 | 0.389 |
NACT Arm | 56.00 | 54.00–58.00 | – | – | – | – | – |
IIIA | |||||||
CCRT Arm | 33.00 | 32.00–34.00 | 0.894 | 0.344 | 1.32 | 0.66–2.63 | 0.424 |
NACT Arm | 43.00 | 38.00–49.00 | – | – | – | – | – |
IIIB | |||||||
CCRT Arm | 43.00 | 41.00–45.00 | 18.99 | <0.001 | 2.09 | 1.47–2.97 | <0.001 |
NACT Arm | 51.00 | 50.00–53.00 | – | – | – | – | – |
IVA | |||||||
CCRT Arm | 35.00 | 32.00–38.00 | 4.47 | 0.03 | 3.19 | 0.98–10.42 | 0.054 |
NACT Arm | 42.00 | 39.00–45.00 | – | – | – | – | – |